These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 365599

  • 1. Gonadotropin secretion in eugonadotropic human males and postmenopausal females under long-term application of a potent analog of gonadotropin-releasing hormone.
    Happ J, Scholz P, Weber T, Cordes U, Schramm P, Neubauer M, Beyer J.
    Fertil Steril; 1978 Dec; 30(6):674-8. PubMed ID: 365599
    [No Abstract] [Full Text] [Related]

  • 2. Gonadotropin and testosterone secretion in normal human males after stimulation with gonadotropin-releasing hormone (GnRH) or potent GnRH analogs using different modes of application.
    Happ J, Hartmann U, Weber T, Cordes U, Beyer J.
    Fertil Steril; 1978 Dec; 30(6):666-73. PubMed ID: 365598
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Short term administration of gonadotropin-releasing hormone analog to a patient with a testosterone-secreting ovarian tumor.
    Kennedy L, Traub AI, Atkinson AB, Sheridan B.
    J Clin Endocrinol Metab; 1987 Jun; 64(6):1320-2. PubMed ID: 3106399
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Gonadotropins and estradiol responses to single intranasal or subcutaneous administration of a luteinizing hormone-releasing hormone agonist in the early follicular phase.
    Lemay A, Metha AE, Tolis G, Faure N, Labrie F, Fazekas AT.
    Fertil Steril; 1983 May; 39(5):668-73. PubMed ID: 6404661
    [Abstract] [Full Text] [Related]

  • 9. Single subcutaneous doses of a luteinizing hormone-releasing hormone antagonist suppress serum gonadotropin and testosterone levels in normal men.
    Pavlou SN, Debold CR, Island DP, Wakefield G, Rivier J, Vale W, Rabin D.
    J Clin Endocrinol Metab; 1986 Aug; 63(2):303-8. PubMed ID: 3088019
    [Abstract] [Full Text] [Related]

  • 10. Suppressive actions of a gonadotropin-releasing hormone antagonist on luteinizing hormone, follicle-stimulating hormone, and prolactin release in estrogen-deficient postmenopausal women.
    Urban RJ, Pavlou SN, Rivier JE, Vale WW, Dufau ML, Veldhuis JD.
    Am J Obstet Gynecol; 1990 May; 162(5):1255-60. PubMed ID: 2111095
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Intranasal application of luteinising-hormone releasing hormone.
    Solbach HG, Wiegelman W.
    Lancet; 1973 Jun 02; 1(7814):1259. PubMed ID: 4122614
    [No Abstract] [Full Text] [Related]

  • 16. Assessment of pituitary response to nasal application of synthetic gonadotropin-releasing hormone in men.
    Potashnik G, Ben-Adereth N, Lunenfeld B, Rofe C.
    Fertil Steril; 1977 Jun 02; 28(6):650-4. PubMed ID: 324823
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Gonadotropin and steroid secretory patterns during chronic treatment with a luteinizing hormone-releasing hormone agonist analog in men.
    Evans RM, Doelle GC, Alexander AN, Uderman HD, Rabin D.
    J Clin Endocrinol Metab; 1984 May 02; 58(5):862-7. PubMed ID: 6423661
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.